后腹腔镜超声引导下微波消融治疗复杂肾肿瘤

doi:10.19723/j.issn.1671-167X.2020.04.034

摘要/Abstract

关键词: 肾肿瘤, 微波消融, 后腹腔镜, 超声引导

中图分类号:

R737.11

纪翔,王义,周哲,赵子臣,果宏峰,王刚,张志宏,晋连超,孙国锋,赵文锋,汪磊,贺利军,李宁忱,那彦群. 后腹腔镜超声引导下微波消融治疗复杂肾肿瘤[J]. 北京大学学报（医学版）, 2020, 52(4): 785-789.

图/表 6

图1

图2

表1

表2

图3

图4

参考文献 22

[1]	Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on renal cell carcinoma: The 2019 update[J]. Eur Urol, 2019,75(5):799-810.
[2]	Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011[J]. Chin J Cancer Res, 2015,27(1):2-12.
[3]	Prins FM, Kerkmeijer LGW, Pronk AA, et al. Renal cell carcinoma: alternative nephron-sparing treatment options for small renal masses, a systematic review[J]. J Endourol, 2017,31(10):963-975.
[4]	Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth[J]. J Urol, 2009,182(3):844-853.
[5]	Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results[J]. J Surg Oncol, 2012,106(3):316-321.
[6]	Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma[J]. Semin Liver Dis, 2010,30(1):52-60.
[7]	Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery[J]. Eur Urol, 2009,56(5):786-793. doi: 10.1016/j.eururo.2009.07.040 pmid: 19665284
[8]	范阳, 董隽, 祖强, 等. 机器人患肾切取、工作台手术联合机器人自体肾移植术在复杂肾肿瘤保留肾单位手术中的应用[J]. 中华泌尿外科杂志, 2019,40(5):340-345.
[9]	Lieberman L, Barod R, Dalela D, et al. Use of main renal artery clamping predominates over minimal clamping techniques during robotic partial nephrectomy for complex tumors[J]. J Endourol, 2017,31(2):149-152. pmid: 27936928
[10]	Wagstaff P, Ingels A, Zondervan P, et al. Thermal ablation in renal cell carcinoma management: a comprehensive review[J]. Curr Opin Urol, 2014,24(5):474-482. pmid: 25051022
[11]	Katsanos K, Mailli L, Krokidis M, et al. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours[J]. Cardiovasc Intervent Radiol, 2014,37(2):427-437.
[12]	Zagoria RJ, Pettus JA, Rogers M, et al. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma[J]. Urology, 2011,77(6):1393-1397. pmid: 21492910
[13]	Li X, Yu J, Liang P, et al. Combination therapy of three-dimensional (3D) visualisation operative treatment planning system and US-guided percutaneous microwave ablation in larger renal cell carcinomas (D >/= 4 cm): preliminary results[J]. Int J Hyperthermia, 2017,33(3):271-277.
[14]	Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2017,15(6):804-834.
[15]	Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices[J]. J Vasc Interv Radiol, 2010,21(8 Suppl):192-203.
[16]	Ong SL, Gravante G, Metcalfe MS, et al. Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review[J]. Eur J Gastroenterol Hepatol, 2009,21(6):599-605.
[17]	Abboud SE, Patel T, Soriano S, et al. Long-term clinical outcomes following radiofrequency and microwave ablation of renal cell carcinoma at a single VA medical center[J]. Curr Probl Diagn Radiol, 2018,47(2):98-102.
[18]	Feng B, Liang P. Local thermal ablation of renal cell carcinoma[J]. Eur J Radiol, 2012,81(3):437-440. pmid: 21239130
[19]	Larcher A, Fossati N, Mistretta F, et al. Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses[J]. Urol Oncol, 2015, 33(1): 22.e1-22.e9. doi: 10.1016/j.urolonc.2014.09.013 pmid: 25443268
[20]	Fazio LM, Downey D, Nguan CY, et al. Intraoperative laparoscopic renal ultrasonography: use in advanced laparoscopic renal surgery[J]. Urology, 2006,68(4):723-727. doi: 10.1016/j.urology.2006.04.022 pmid: 17070341
[21]	Castle SM, Salas N, Leveillee RJ. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up[J]. Urology, 2011,77(4):792-797. doi: 10.1016/j.urology.2010.12.028
[22]	Uhlig J, Strauss A, Rucker G, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis[J]. Eur Radiol, 2019,29(3):1293-1307. doi: 10.1007/s00330-018-5660-3 pmid: 30255245

相关文章 15

[1]	王滨帅,邱敏,张前进,田茂锋,刘磊,王国良,陆敏,田晓军,张树栋. 6例肾尤文肉瘤伴静脉瘤栓的诊治[J]. 北京大学学报（医学版）, 2024, 56(4): 636-639.
[2]	虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报（医学版）, 2024, 56(4): 661-666.
[3]	薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报（医学版）, 2023, 55(5): 802-811.
[4]	邱敏,宗有龙,王滨帅,杨斌,徐楚潇,孙争辉,陆敏,赵磊,卢剑,刘承,田晓军,马潞林. 腹腔镜肾部分切除术治疗中高复杂程度肾肿瘤的效果[J]. 北京大学学报（医学版）, 2023, 55(5): 833-837.
[5]	周利群,徐纯如. 机器人时代中央型肾肿瘤的手术治疗策略[J]. 北京大学学报（医学版）, 2022, 54(4): 587-591.
[6]	李新飞, 彭意吉, 余霄腾, 熊盛炜, 程嗣达, 丁光璞, 杨昆霖, 唐琦, 米悦, 吴静云, 张鹏, 谢家馨, 郝瀚, 王鹤, 邱建星, 杨建, 李学松, 周利群. 肾部分切除术前CT三维可视化评估标准的初步探究[J]. 北京大学学报（医学版）, 2021, 53(3): 613-622.
[7]	邱敏,费月阳,邓绍晖,刘承,卢剑,何为,陆敏,田晓军,张树栋,马潞林. 后肾腺瘤的诊治经验及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(2): 417-419.
[8]	毕海,黄毅,马潞林,陆敏,张树栋,张洪宪. 3例肾尤文肉瘤合并下腔静脉癌栓的诊治[J]. 北京大学学报（医学版）, 2020, 52(5): 985-989.
[9]	马闰卓,夏海缀,陆敏,张智荧,张启鸣,卢剑,王国良,马潞林. 输尿管镜活体组织检查对上尿路尿路上皮癌根治性手术的影响[J]. 北京大学学报（医学版）, 2019, 51(4): 665-672.
[10]	田晓军,邱敏,刘茁,肖若陶,黄毅,王国良,侯小飞,张树栋,庄申榕,马潞林. 微创手术治疗肾癌合并Mayo 0~2级静脉癌栓的单中心研究[J]. 北京大学学报（医学版）, 2018, 50(6): 1053-1056.
[11]	徐奔，张喆楠，罗程，宋海峰，张骞. 后腹腔镜下肿瘤吸除术与肾部分切除术治疗肾血管平滑肌脂肪瘤的安全性与有效性对比[J]. 北京大学学报(医学版), 2018, 50(4): 700-704.
[12]	黄子雄，张晓鹏，董森，刘士军，杨荣利，周宇石，马伟国. 肾黏液性小管和梭形细胞癌合并骨转移1例及文献回顾[J]. 北京大学学报(医学版), 2018, 50(4): 732-735.
[13]	马伟国，秦彩朋，于路平，张晓鹏，刘士军，王永顺，白文俊，徐涛. 后腹腔镜下孤立肾采用肾动脉非阻断法行保留肾单位肾肿瘤剜除术的疗效评价[J]. 北京大学学报(医学版), 2018, 50(4): 759-761.
[14]	叶剑飞，马潞林，赵磊，王国良. 腔静脉节段切除术在处理侵犯腔静脉的肾肿瘤瘤栓中的应用[J]. 北京大学学报(医学版), 2018, 50(1): 183-187.
[15]	刘畅, 崔立刚, 王宏磊. 肾尤文氏肉瘤/原始神经外胚层肿瘤: 1例报道并文献复习[J]. 北京大学学报(医学版), 2017, 49(5): 919-923.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Patient No.	Age/ years	Gender	Side/tumor number	Comorbidities	ASA grade	Number of ablation punctures	Ablation time/min	Operation time/min	EBL /mL	Drainage time/d	Histopathology	Follow-up/ months	Local efficacy
1	49	F	Left/1	Schizophrenia	Ⅱ	4	21	130	30	3	Hamartoma	65	CR
2	74	M	Right/1	Renal insufficiency, CHD, hypertension, mild cerebral infarction, bilateral knee arthritis	Ⅳ	4	20	105	20	4	Clear cell carcinoma	42	CR
3	68	M	Right/1	COPD, hypertension	Ⅲ	3	17	80	10	2	Papillary cell carcinoma	61	CR
4	56	F	Right/1	Hypertension, postoperative colon cancer	Ⅲ	4	21	95	20	2	Clear cell carcinoma	60	CR
5	61	F	Left/1	CHD, DM, hypertension	Ⅲ	4	20	90	15	3	Clear cell carcinoma	52	CR
6	64	M	Left/2	Renal insufficiency, DM, COPD, tracheotomy for laryngeal carcinoma	Ⅳ	7	32	120	20	2	Clear cell carcinoma	41	CR
7	72	M	Left/1	Mild cerebral infarction, hypertension	Ⅲ	5	28	116	30	3	Clear cell carcinoma	37	CR
8	84	M	Left/1	Renal insufficiency, hypertension, CHD	Ⅳ	5	26	95	40	3	Clear cell carcinoma	33	CR
9	53	M	Left/2	Renal insufficiency, solitary kidney, VHL disease causes lung metastasis	Ⅲ	5	23	115	20	3	Clear cell carcinoma	29	CR
10	63	F	Left/1	Hypertension, drug-induced hepatic cirrhosis, hepatic insufficiency	Ⅲ	6	27	110	15	4	Hamartoma	27	PR

Patient No.	(R)Radius		(E)Exophytic		(N)Nearness		(A)Anterior/ posterior/x^△	(L)Location score	Total score+ Suffix “h”^*
Patient No.	Score	Maximal diameter/cm	Score	Exophytic properties/%	Score	Nearness to the renal pelvis/mm	(A)Anterior/ posterior/x^△	(L)Location score	Total score+ Suffix “h”^*
1	2	4.2	2	10%	3	1	a	3	10ah
2	2	4.5	2	30%	3	2	x	3	10xh
3	1	3.7	2	20%	2	6	a	2	7a
4	2	4.2	2	10%	2	6	x	2	8x
5	2	4.1	1	70%	2	5	p	2	7p
6 (2 tumors)	2 & 1	4.1 & 1.5	2 & 3	15% & 0%	3 & 1	4 & 20	x & a	3 & 1	10x & 6a
7	2	5.2	2	40%	3	3	a	3	10ah
8	2	5.3	1	55%	3	1	x	1	7xh
9 (2 tumors)	1 & 1	2 & 1.5	2 & 2	30% & 10%	1 & 1	21 & 16	a & p	1 & 2	5a & 6p
10	2	4.5	3	0%	3	2	p	3	11p

后腹腔镜超声引导下微波消融治疗复杂肾肿瘤

RICH HTML

PDF (PC)

摘要/Abstract

引用本文

使用本文

图/表 6

参考文献 22

相关文章 15

Metrics

本文评价

推荐阅读 0